Alessandro Piovesan
Asti, 14100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Next-Generation Sequencing in Differentiated Thyroid Cancer Patients Treated with Lenvatinib: Results and Challenges in Real-Life Practice.
Journal: Current oncology (Toronto, Ont.)
Published: May 09, 2026
Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies.
Journal: Biomedicines
Published: November 21, 2025
Prospective Validation of ATA Risk Score for Papillary Thyroid Microcarcinoma: An ITCO Real-World Study.
Journal: The Journal of clinical endocrinology and metabolism
Published: September 20, 2024
Tailored management of advanced thyroid cancer patients treated with lenvatinib or vandetanib: the role of a multimodal approach.
Journal: Endocrine
Published: July 30, 2024
Association of type 1 stiff-person syndrome and insulinoma: a case report and narrative review.
Journal: Hormones (Athens, Greece)
Published: July 10, 2024
Parathyroid carcinoma and atypical parathyroid tumor: analysis of an Italian database.
Journal: European journal of endocrinology
Published: May 08, 2024
A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis.
Journal: Thyroid : official journal of the American Thyroid Association
Published: September 19, 2023
Immune-related thyroid dysfunctions during anti PD-1/PD-L1 inhibitors: new evidence from a single centre experience.
Journal: Clinical and experimental medicine
Published: April 01, 2023
Recurrence and mortality rate in an Italian multi-center case series of parathyroid atypical adenomas and carcinomas.
Journal: Frontiers in endocrinology
Published: February 03, 2023
A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study.
Journal: The Journal of clinical endocrinology and metabolism
Published: October 06, 2022
Management of Progressive Radioiodine-Refractory Thyroid Carcinoma: Current Perspective.
Journal: Cancer management and research
Published: July 31, 2022
Last Updated: 09/26/2026